Postoperative Electrical Muscle Stimulation (POEMS)

NCT ID: NCT04199936

Last Updated: 2021-05-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-11-18

Study Completion Date

2021-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients lose a significant amount of muscle following major abdominal surgery. This is partly due to a catabolic response to the surgical insult and inflammation, but is also probably due to a lack of muscle use secondary to immobility.

This study will aim to assess whether some or even all of postoperative muscle loss in the upper leg muscle group is preventable through electrical muscle stimulation to mimic physical activity.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Following major gastrointestinal surgery patients may loose around 6 % of their skeletal muscle mass in the first 5 days. Whilst some of this loss is as a result of inflammation and starvation, some is due to muscle disuse.

Studies have shown that patients spend 96% of their time being sedentary in the first 5 days following major abdominal surgery and by day 5 are still taking a median of less than 500 steps per day. Studies of healthy volunteers who undergo similar muscle disuse loose approximately 3.5% of skeletal muscle mass over the same time period, indicating that around half of postoperative muscle loss may be due to immobility.

Through the use of electrical muscle stimulation, this study will aim to mimic high levels of exercise in the quadriceps of patients who have undergo major gastrointestinal surgery to see whether this reduces or prevents muscle loss. Patients muscles will be measured using ultrasound and DXA and neuromuscular function will be measured using electromyography.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Muscle Atrophy Postoperative Complications

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Single centre pilot study (randomised internal control trial)
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Outcome Assessors
ultrasound images, DXA scans and EMG results will be given coded labeling by a separate researcher so that investigator analysing results will be blinded to whether scans / EMG results are from intervention or control leg, or start of finish.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

EMG leg

Quadriceps muscle group of postoperative patients randomly selected leg which will undergo electrical muscle stimulation for upto 2 hours on each postoperative day

Group Type EXPERIMENTAL

Electrical Muscle stimulation

Intervention Type DEVICE

Electrical muscle stimulation

Control leg

Quadriceps muscle group of postoperative patients leg not selected to undergo electrical muscle stimulation

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Electrical Muscle stimulation

Electrical muscle stimulation

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients undergoing major segmental colonic resections or gastric/oesophageal resection
* Sufficient mobility and fitness to complete normal enhanced recovery protocols following surgery
* Ability to give informed consent

Exclusion Criteria

* Pre-existing neuromuscular disease (including parkinson's disease)
* Pacemaker, implantable cardiac defibrillator or other implanted nerve stimulator device
* Metalwork in both upper legs
* Dementia
* Inability to give informed consent
* Disability preventing normal mobilisation after surgery
* Symptomatic peripheral vascular disease
* Chronic kidney failure of chronic heart failure
* Intubation for \> 24 hours post operation
* Return to theatre for surgical complication within first 5 days post operation
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Nottingham

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jon N Lund, MBBCh, DM

Role: PRINCIPAL_INVESTIGATOR

University of Nottingham

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Royal Derby Hospital

Derby, Derbyshire, United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Edward J Hardy, MBBCh

Role: CONTACT

07890429460

Bethan E Phillips, PhD

Role: CONTACT

01332724676

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Edward J O Hardy, MBBCh

Role: primary

01332340131

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

274048

Identifier Type: OTHER

Identifier Source: secondary_id

19089

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.